Get started
Author

Ana C. Fortuna

Observed names: A. C. Fortuna, A. Fortuna, Ana Fortuna, Fortuna Ana, Fortuna, Ana
Observed institutions: Bial (Portugal), University of Beira Interior, Universidade do Porto, Cadila Pharmaceuticals (India), Centro de Neurociências e Biologia Celular, Unidade Local de Saúde do Algarve, University of Coimbra, Universidade Nova de Lisboa
ORCID: 0000-0001-6981-6639
Observed ORCID: 0000-0001-6981-6639
OpenAlex ID: A5031340729
Intranasal Drug Delivery: How, Why and What for?
2009 · Anaísa Pires, Ana Fortuna, et al. · Journal of Pharmacy & Pharmaceutical Sciences · 639
PDF
Blood–brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
2014 · Joana Bicker, Gilberto Alves, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 262
Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules
2014 · Ana Fortuna, Gilberto Alves, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 211
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Review of Classical and New Compounds: Part-I
2019 · Raquel Vieira, Selma B. Souto, et al. · Pharmaceuticals · 188
PDF
Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples—A review
2012 · Joana Bicker, Ana Fortuna, et al. · Analytica Chimica Acta · 183
Air-liquid interface (ALI) impact on different respiratory cell cultures
2023 · Soraia Silva, Joana Bicker, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 146
Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology
2014 · Ana Ferreira, Márcio Rodrigues, et al. · Phytochemistry Reviews · 106
Impact of direct oral anticoagulant off‐label doses on clinical outcomes of atrial fibrillation patients: A systematic review
2019 · Joana Santos, Natália António, et al. · British Journal of Clinical Pharmacology · 105
Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer’s disease: Past, present and future
2022 · Filipa Gouveia, Antoni Camins, et al. · Ageing Research Reviews · 96
Intranasal administration of carbamazepine to mice: A direct delivery pathway for brain targeting
2014 · Ana Serralheiro, Gilberto Alves, et al. · European Journal of Pharmaceutical Sciences · 96
Analytical methods for determination of new fluoroquinolones in biological matrices and pharmaceutical formulations by liquid chromatography: a review
2012 · Joana Sousa, Gilberto Alves, et al. · Analytical and Bioanalytical Chemistry · 93
Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics
2020 · Joana Bicker, Gilberto Alves, et al. · British Journal of Pharmacology · 92
ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches
2019 · Kevin Leandro, Joana Bicker, et al. · Pharmacological Research · 81
Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice
2015 · Ana Serralheiro, Gilberto Alves, et al. · International Journal of Pharmaceutics · 77
First HPLC–UV method for rapid and simultaneous quantification of phenobarbital, primidone, phenytoin, carbamazepine, carbamazepine-10,11-epoxide, 10,11-trans-dihydroxy-10,11-dihydrocarbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma
2013 · Ana Serralheiro, Gilberto Alves, et al. · Journal of Chromatography B · 74
Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II
2019 · Raquel Vieira, Selma B. Souto, et al. · Journal of Clinical Medicine · 71
PDF
Nose-to-brain delivery of levetiracetam after intranasal administration to mice
2019 · Joana Gonçalves, Joana Bicker, et al. · International Journal of Pharmaceutics · 71
Drug-metabolizing Enzymes and Efflux Transporters in Nasal Epithelium: Influence on the Bioavailability of Intranasally Administered Drugs
2016 · Paula Oliveira, Ana Fortuna, et al. · Current Drug Metabolism · 71
Development and validation of an HPLC-UV method for the simultaneous quantification of carbamazepine, oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma
2010 · Ana Fortuna, Joana Sousa, et al. · Analytical and Bioanalytical Chemistry · 69
Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders
2022 · Jordi Olloquequi, Amanda Cano, et al. · Biomedicine & Pharmacotherapy · 68
PDF
Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma
2020 · Filipa Gouveia, Joana Bicker, et al. · Journal of Pharmaceutical and Biomedical Analysis · 66
A new PAMPA model using an in-house brain lipid extract for screening the blood–brain barrier permeability of drug candidates
2016 · Joana Bicker, Gilberto Alves, et al. · International Journal of Pharmaceutics · 65
Spray dried powders for nasal delivery: Process and formulation considerations
2022 · Patrícia Henriques, Ana Fortuna, et al. · European Journal of Pharmaceutics and Biopharmaceutics · 63
Rethinking carbamazepine oral delivery using polymer-lipid hybrid nanoparticles
2018 · Raquel Ana, Maria Mendes, et al. · International Journal of Pharmaceutics · 61
Liquid chromatographic assay based on microextraction by packed sorbent for therapeutic drug monitoring of carbamazepine, lamotrigine, oxcarbazepine, phenobarbital, phenytoin and the active metabolites carbamazepine-10,11-epoxide and licarbazepine
2014 · Ana Ferreira, Márcio Rodrigues, et al. · Journal of Chromatography B · 60
Works count: 158
Citation count: 5,268
H-index: 39
I10-index: 98
Year
Topic
Type